In the News

A new quantitative imaging bone biomarker has been identified that can assess response and is prognostic for survival in men with metastatic castration-resistant prostate cancer (mCRPC). 

Read More ›

Patients with metastatic renal cell carcinoma (mRCC) who do not meet eligibility criteria for clinical trials have worse outcomes on targeted therapy compared with eligible patients. In fact, extrapolating results of clinical trials to ineligible patients leads to inferior response rates (RRs), progression-free survival (PFS), and overall survival (OS). 

Read More ›

Colonoscopy screening and removal of adenomatous polyps reduced the risk of colorectal cancer death by 53% in a recent study reported in the New England Journal of Medicine (2012;366:687-696)

Read More ›

Patients may not understand the information medical care providers give them for a number of reasons, but significant among them is poor healthcare literacy, which is the ability to understand health information and to use that information to make good decisions about health and medical care. Unfortunately, about 33% of the adult population in the United States has limited healthcare literacy. Yet, the need for this proficiency is greater than ever because medical care has become progressively more complex. Let us take a look at healthcare literacy facts and figures:

Read More ›

Although cancer patients who undergo radiation therapy frequently have acute and chronic skin reactions, there are no hard and fast guidelines on management of radiation-induced skin reactions or the best products to use. Each center or practice should develop its own clinical guide about how patients should manage skin reactions and which products are recommended for patient use, said Maureen McQuestion, RN, Princess Margaret Hospital, Toronto, Ontario, Canada. Read More ›


The National Women’s Hall of Fame recently inducted Loretta C. Ford, RN, EdD, PNP, FAAN, FAANP, along with 10 other American women who have made valuable and enduring contributions to our nation. These women were formally inducted on September 30 and October 1, 2011, in Seneca Falls, New York, the birthplace of the American Women’s Rights Movement.

Read More ›

Thanks to medical research, there are nearly 12 million cancer survivors living in the United States today. And the research continues: There are approximately 400 new cancer therapies in preclinical and clinical development. As progress continues to treat those with cancer, let’s examine the statistics related to clinical trial participation.


From 1996 through 2002, National Cancer Institute (NCI)-sponsored cooperative group nonsurgical treatment trials for breast, colorectal, lung, and prostate cancers enrolled 75,215 patients:

Read More ›

Each year, a significant number of adolescents and young adults (AYAs), aged 15 to 39 years, are faced with a cancer diagnosis. And yet, there has been a lack in progress when it comes to treating this age-group. To better understand the facts and figures associated with these patients, let’s take a closer look at AYA oncology by the numbers. Over the past 30 years, cancer incidence in young adults has increased more than any other age-group…

Read More ›

Patients with HER2+ breast cancer who develop resistance to trastuzumab may soon have an alternative therapy, according to recent findings published in Clinical Cancer Research. This therapy involves HER2-Affitoxin, a protein that combines HER2-specific affibody molecules and a modified bacterial toxin, PE38, according to study investigator Jacek Capala, PhD, DSc, of the National Cancer Institute. Read More ›


A recently developed urine test can assist in the early detection of and treatment decisions regarding prostate cancer, a study from the University of Michigan Comprehensive Cancer Center and the Michigan Center for Translational Pathology finds.

Designed to supplement an elevated prostate-specific antigen (PSA) screening result, this test also defines men at highest risk for clinically significant prostate cancer and could delay or negate the need for a needle biopsy in some patients.

Read More ›

Page 9 of 11


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: